» Articles » PMID: 24771043

Apparent Reduction of ADAM10 in Scrapie-infected Cultured Cells and in the Brains of Scrapie-infected Rodents

Overview
Journal Mol Neurobiol
Date 2014 Apr 29
PMID 24771043
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

It has been described that A disintegrin and metalloproteinase (ADAM10) may involve in the physiopathology of prion diseases, but the direct molecular basis still remains unsolved. In this study, we confirmed that ADAM10 was able to cleave recombinant human prion protein in vitro. Using immunoprecipitation tests (IP) and immunofluorescent assays (IFA), reliable molecular interaction between the native cellular form of PrP (PrP(C)) and ADAM10 was observed not only in various cultured neuronal cell lines but also in brain homogenates of healthy hamsters and mice. Only mature ADAM10 (after removal of its prodomain) molecules showed the binding activity with the native PrP(C). Remarkably more prion protein (PrP)-ADAM10 complexes were detected in the membrane fraction of cultured cells. In the scrapie-infected SMB cell model, the endogenous ADAM10 levels, especially the mature ADAM10, were significantly decreased in the fraction of cell membrane. IP and IFA tests of prion-infected SMB-S15 cells confirmed no detectable PrP-ADAM10 complex in the cellular lysates and PrP-ADAM10 co-localization on the cell surface. Furthermore, we demonstrated that the levels of ADAM10 in the brain homogenates of scrapie agent 263K-infected hamsters and agent ME7-infected mice were also almost diminished at the terminal stage, showing time-dependent decreases during the incubation period. Our data here provide the solid molecular basis for the endoproteolysis of ADAM10 on PrP molecules and interaction between ADAM10 and PrP(C). Obvious loss of ADAM10 during prion infection in vitro and in vivo highlights that ADAM10 may play essential pathophysiological roles in prion replication and accumulation.

Citing Articles

Aberrance of GAP43/p-GAP43 Closely Associates with the Pathology of Neuron Loss in Prion-Infected Rodent Models.

Jia X, Chen C, Hu C, Wu Y, Chao Z, Zeng J Mol Neurobiol. 2024; 62(4):4435-4451.

PMID: 39453517 DOI: 10.1007/s12035-024-04568-9.


Post-translational modifications in prion diseases.

Bizingre C, Bianchi C, Baudry A, Alleaume-Butaux A, Schneider B, Pietri M Front Mol Neurosci. 2024; 17:1405415.

PMID: 39011540 PMC: 11247024. DOI: 10.3389/fnmol.2024.1405415.


Different Aberrant Changes of mGluR5 and Its Downstream Signaling Pathways in the Scrapie-Infected Cell Line and the Brains of Scrapie-Infected Experimental Rodents.

Hu C, Chen C, Xia Y, Chen J, Yang W, Wang L Front Cell Dev Biol. 2022; 10:844378.

PMID: 35646890 PMC: 9133610. DOI: 10.3389/fcell.2022.844378.


Alternative complement pathway is activated in the brains of scrapie-infected rodents.

Chen C, Lv Y, Hu C, Xu X, Zhang R, Xiao K Med Microbiol Immunol. 2019; 209(1):81-94.

PMID: 31720785 DOI: 10.1007/s00430-019-00641-6.


Decrease of RyR2 in the prion infected cell line and in the brains of the scrapie infected mice models and the patients of human prion diseases.

Shi Q, Li J, Ma Y, Gao L, Xiao K, Wang J Prion. 2018; 12(3-4):175-184.

PMID: 29676187 PMC: 6277195. DOI: 10.1080/19336896.2018.1465162.


References
1.
Altmeppen H, Prox J, Puig B, Kluth M, Bernreuther C, Thurm D . Lack of a-disintegrin-and-metalloproteinase ADAM10 leads to intracellular accumulation and loss of shedding of the cellular prion protein in vivo. Mol Neurodegener. 2011; 6:36. PMC: 3224557. DOI: 10.1186/1750-1326-6-36. View

2.
Aguzzi A, Calella A . Prions: protein aggregation and infectious diseases. Physiol Rev. 2009; 89(4):1105-52. DOI: 10.1152/physrev.00006.2009. View

3.
Vincent B, Paitel E, Saftig P, Frobert Y, Hartmann D, De Strooper B . The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J Biol Chem. 2001; 276(41):37743-6. DOI: 10.1074/jbc.M105677200. View

4.
Yamamoto S, Higuchi Y, Yoshiyama K, Shimizu E, Kataoka M, Hijiya N . ADAM family proteins in the immune system. Immunol Today. 1999; 20(6):278-84. DOI: 10.1016/s0167-5699(99)01464-4. View

5.
Altmeppen H, Puig B, Dohler F, Thurm D, Falker C, Krasemann S . Proteolytic processing of the prion protein in health and disease. Am J Neurodegener Dis. 2013; 1(1):15-31. PMC: 3560451. View